Published in Biomaterials on April 02, 2010
Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration. Stem Cell Res Ther (2012) 1.56
Bone regeneration potential of stem cells derived from periodontal ligament or gingival tissue sources encapsulated in RGD-modified alginate scaffold. Tissue Eng Part A (2013) 1.11
Alginate hydrogel as a promising scaffold for dental-derived stem cells: an in vitro study. J Mater Sci Mater Med (2012) 1.02
The use of micro- and nanospheres as functional components for bone tissue regeneration. Tissue Eng Part B Rev (2011) 0.98
Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation. Biotechnol Bioeng (2013) 0.90
Tailoring adipose stem cell trophic factor production with differentiation medium components to regenerate chondral defects. Tissue Eng Part A (2013) 0.83
One-dimensional self-assembly of mouse embryonic stem cells using an array of hydrogel microstrands. Biomaterials (2011) 0.82
3D porous calcium-alginate scaffolds cell culture system improved human osteoblast cell clusters for cell therapy. Theranostics (2015) 0.78
In Vivo Assessment of Bone Regeneration in Alginate/Bone ECM Hydrogels with Incorporated Skeletal Stem Cells and Single Growth Factors. PLoS One (2015) 0.78
Adipose stem cell microbeads as production sources for chondrogenic growth factors. J Stem Cells Regen Med (2014) 0.77
Ethyl-3,4-dihydroxybenzoate with a dual function of induction of osteogenic differentiation and inhibition of osteoclast differentiation for bone tissue engineering. Tissue Eng Part A (2014) 0.75
Calcium alginate/dextran methacrylate IPN beads as protecting carriers for protein delivery. J Mater Sci Mater Med (2012) 0.75
Nanostructured injectable cell microcarriers for tissue regeneration. Nanomedicine (Lond) (2016) 0.75
Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell (2002) 19.15
Self-assembly and mineralization of peptide-amphiphile nanofibers. Science (2001) 8.90
Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials (1999) 4.69
Microencapsulated islets as bioartificial endocrine pancreas. Science (1980) 4.35
Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med (2001) 2.06
Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res (2001) 1.95
Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J Cell Sci (1994) 1.93
von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int (2003) 1.92
Crystallization at Inorganic-organic Interfaces: Biominerals and Biomimetic Synthesis. Science (1993) 1.78
Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials (2005) 1.74
Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions. J Biomed Mater Res B Appl Biomater (2004) 1.51
Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules (2004) 1.44
Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J Biomed Mater Res (2001) 1.42
Effect of substrate mechanics on chondrocyte adhesion to modified alginate surfaces. Arch Biochem Biophys (2004) 1.26
Mechanisms of inhibition of calcification. Clin Orthop Relat Res (1989) 1.23
Tissue engineering of autologous cartilage for craniofacial reconstruction by injection molding. Plast Reconstr Surg (2003) 1.22
The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials (2009) 1.18
Bone tissue engineering using human adipose-derived stem cells and honeycomb collagen scaffold. J Biomed Mater Res A (2008) 1.07
Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am (2005) 1.05
High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy. Bone Marrow Transplant (2007) 1.04
Transforming growth factor-beta in calcium alginate beads for the treatment of articular cartilage defects in the rabbit. Arthroscopy (2002) 1.03
Safety of bisphosphonates in the treatment of osteoporosis. Am J Med (2009) 1.02
Caveolin-1 knockout mice have increased bone size and stiffness. J Bone Miner Res (2007) 1.01
Acid-base buffering in organ preservation solutions as a function of temperature: new parameters for comparing buffer capacity and efficiency. Cryobiology (2002) 0.95
Fabrication of tissue engineered tympanic membrane patches using computer-aided design and injection molding. Laryngoscope (2004) 0.94
Shape retaining injectable hydrogels for minimally invasive bulking. J Urol (2004) 0.93
Controlling the size of alginate gel beads by use of a high electrostatic potential. J Microencapsul (2002) 0.91
Regulation of growth plate chondrocytes by 1,25-dihydroxyvitamin D3 requires caveolae and caveolin-1. J Bone Miner Res (2006) 0.91
Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. III. Biocompatibility Of smaller versus standard microcapsules. J Biomed Mater Res (1999) 0.91
Controlled degradation of hydrogels using multi-functional cross-linking molecules. Biomaterials (2004) 0.89
Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J Control Release (2009) 0.88
Barium: rationale for a new oral reference dose. J Toxicol Environ Health B Crit Rev (2001) 0.87
Physiochemical principles of cardiovascular calcification. Z Kardiol (2001) 0.84
Calculus formation and inhibition. Adv Dent Res (1994) 0.82
Unusual donor site reactions to calcium alginate dressings. Burns (2000) 0.81
Ionotropic alginate beads for controlled intestinal protein delivery: effect of chitosan and barium counter-ions on entrapment and release. J Microencapsul (2005) 0.80
Physico-chemical and mass transfer considerations in microencapsulation. Ann N Y Acad Sci (1999) 0.80
Neocartilage from human mesenchymal stem cells in alginate: implied timing of transplantation. J Biomed Mater Res A (2005) 0.79
In vitro characterization of TGF-beta1 release from genetically modified fibroblasts in Ca(2+)-alginate microcapsules. ASAIO J (2005) 0.78
Apparent binding of ionized calcium by various buffers. Clin Chem (1985) 0.77
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem (2004) 2.25
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res (2012) 2.05
Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood (2010) 1.98
Mid-Term Dental and Nerve-Related Complications of Infant Distraction for Robin Sequence. Plast Reconstr Surg (2016) 1.93
The effects of combined micron-/submicron-scale surface roughness and nanoscale features on cell proliferation and differentiation. Biomaterials (2011) 1.79
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
The role of muscle flaps in wound salvage after vascular graft infections: the Emory experience. Plast Reconstr Surg (2006) 1.75
Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell (2009) 1.72
Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage. Biomaterials (2010) 1.69
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
Infrared assessment of bone quality: a review. Clin Orthop Relat Res (2011) 1.63
Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am (2005) 1.61
Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment. Bone (2012) 1.60
Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration. Stem Cell Res Ther (2012) 1.56
Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res (2009) 1.54
Use of dermal matrix to prevent capsular contracture in aesthetic breast surgery. Plast Reconstr Surg (2012) 1.52
Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res (2009) 1.52
Alginate microencapsulation technology for the percutaneous delivery of adipose-derived stem cells. Ann Plast Surg (2010) 1.52
Osteoblast-like cells are sensitive to submicron-scale surface structure. Clin Oral Implants Res (2006) 1.49
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone (2009) 1.47
Effects of surface roughness and maximum load on the mechanical properties of cancellous bone measured by nanoindentation. J Biomed Mater Res A (2006) 1.46
Effects of tissue age on bone tissue material composition and nanomechanical properties in the rat cortex. J Biomed Mater Res A (2010) 1.45
Implant materials generate different peri-implant inflammatory factors: poly-ether-ether-ketone promotes fibrosis and microtextured titanium promotes osteogenic factors. Spine (Phila Pa 1976) (2015) 1.44
Regenerative medicine: Are calcium phosphate ceramics 'smart' biomaterials? Nat Rev Rheumatol (2011) 1.42
Use of rectus abdominis muscle flap as adjunct to bladder neck closure in patients with neurogenic incontinence: preliminary experience. J Urol (2010) 1.42
Stimulation of growth factor synthesis by electric and electromagnetic fields. Clin Orthop Relat Res (2004) 1.41
Effect of micrometer-scale roughness of the surface of Ti6Al4V pedicle screws in vitro and in vivo. J Bone Joint Surg Am (2008) 1.41
Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials (2007) 1.37
Dilatational band formation in bone. Proc Natl Acad Sci U S A (2012) 1.32
Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc (2005) 1.31
Mineral changes in osteoporosis: a review. Clin Orthop Relat Res (2006) 1.31
Contribution of mineral to bone structural behavior and tissue mechanical properties. Calcif Tissue Int (2010) 1.30
Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem (2005) 1.27
A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem (2007) 1.25
Potential of chemically modified hydrophilic surface characteristics to support tissue integration of titanium dental implants. J Biomed Mater Res B Appl Biomater (2009) 1.23
Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum (2006) 1.23
Differential responses of osteoblast lineage cells to nanotopographically-modified, microroughened titanium-aluminum-vanadium alloy surfaces. Biomaterials (2012) 1.20
DSPP effects on in vivo bone mineralization. Bone (2008) 1.19
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res (2002) 1.17
Integrin beta1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D3. Biomaterials (2006) 1.17
Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol (2010) 1.17
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone (2005) 1.13
Effect of cleaning and sterilization on titanium implant surface properties and cellular response. Acta Biomater (2011) 1.12
Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy. Biomaterials (2010) 1.11
The roles of titanium surface micro/nanotopography and wettability on the differential response of human osteoblast lineage cells. Acta Biomater (2012) 1.11
Consideration of systemic hormone status when treating patients with osteopenia. J Periodontol (2003) 1.10
Mediation of osteogenic differentiation of human mesenchymal stem cells on titanium surfaces by a Wnt-integrin feedback loop. Biomaterials (2011) 1.10
A review of polyvinyl alcohol and its uses in cartilage and orthopedic applications. J Biomed Mater Res B Appl Biomater (2012) 1.10
Bone quality: from bench to bedside: opening editorial comment. Clin Orthop Relat Res (2011) 1.09
Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am (2007) 1.08
Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem (2003) 1.08
Fourier transform infrared imaging microspectroscopy and tissue-level mechanical testing reveal intraspecies variation in mouse bone mineral and matrix composition. Calcif Tissue Int (2008) 1.08
Osteoblasts exhibit a more differentiated phenotype and increased bone morphogenetic protein production on titanium alloy substrates than on poly-ether-ether-ketone. Spine J (2012) 1.08
Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol (2008) 1.06
The synergistic effects of 3-D porous silk fibroin matrix scaffold properties and hydrodynamic environment in cartilage tissue regeneration. Biomaterials (2010) 1.05
Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am (2005) 1.05
Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces. Biomaterials (2009) 1.05
Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res (2002) 1.03
Microstructure and nanomechanical properties in osteons relate to tissue and animal age. J Biomech (2010) 1.03
Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem (2011) 1.02
Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res (2003) 1.02
Caveolin-1 knockout mice have increased bone size and stiffness. J Bone Miner Res (2007) 1.01
Spectroscopically determined collagen Pyr/deH-DHLNL cross-link ratio and crystallinity indices differ markedly in recombinant congenic mice with divergent calculated bone tissue strength. Connect Tissue Res (2003) 1.00
Fourier transform infrared imaging of femoral neck bone: reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controls. J Bone Miner Res (2013) 0.99
Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36). J Biol Chem (2012) 0.99
Osteoblast maturation and new bone formation in response to titanium implant surface features are reduced with age. J Bone Miner Res (2012) 0.99
An objective evaluation of breast symmetry and shape differences using 3-dimensional images. Ann Plast Surg (2005) 0.98
The responses to surface wettability gradients induced by chitosan nanofilms on microtextured titanium mediated by specific integrin receptors. Biomaterials (2012) 0.98
Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Biochim Biophys Acta (2002) 0.98
Decorin modulates collagen matrix assembly and mineralization. Matrix Biol (2008) 0.98
Mandibular distraction osteogenesis in Pierre Robin sequence: application of a new internal single-stage resorbable device. Plast Reconstr Surg (2005) 0.97